Daily statin cuts cardiovascular risk in HIV

From Medscape Medical News, 24 July 2023 Statins should be considered for primary prevention in people living with HIV who are at low-to-moderate risk of cardiovascular disease, according to final data from the REPRIEVE trial that show pitavastatin therapy is associated with a significantly lower risk of cardiovascular events than placebo. “There was a significant 35% lower Continue reading Daily statin cuts cardiovascular risk in HIV

Cannabis linked to serious cardiovascular complications

From Medicine Today, June 2014: Cannabis use is associated with a significant increase in the risk of serious cardiovascular complications such as acute coronary syndrome, arteriopathies and acute cerebral angiopathy, according to data from the French Addictovigilance Network. Researchers found 1.8% of the 1979 cannabis-related reports to the Network, which collects physician data on serious Continue reading Cannabis linked to serious cardiovascular complications